Douglas W. Pagan
CIK 1628880 · Chief Financial Officer · last filed 2026-04-20
Douglas W. Pagan is a Chief Financial Officer who has filed 27 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for KLRA, was dated Apr 20, 2026. Across all open-market trades the lifetime net is −$698.0K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
27
-$698.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRA | Chief Financial Officer | — | — | — | $0 | 1 | 2026-04-20 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Chief Financial Officer | 0 | $38.22 | $0 | $0 | 5 | 2021-12-29 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 35,943 | $0.87 | $31.1K | $0 | 3 | 2020-01-03 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Chief Financial Officer | 70,807 | $2.23 | $157.9K | -$698.0K | 18 | 2019-04-08 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | KLRA | Grant (A) | — | $0 | EDGAR |
| 2021-12-29 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | −7,775 | -$297.4K | EDGAR |
| 2021-12-17 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | +1,448 | -$22.9K | EDGAR |
| 2021-06-17 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | +4,821 | -$71.6K | EDGAR |
| 2021-01-12 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Mixed | −4,164 | -$94.7K | EDGAR |
| 2019-04-08 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Mixed | −70,250 | $0 | EDGAR |
| 2019-02-28 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +37,000 | $0 | EDGAR |
| 2019-02-07 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Sell (S) | −2,495 | -$16.9K | EDGAR |